Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 2: Model for the Drug-combination Nanoparticles-Reference-Cited by-同舟云学术

Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 2: Model for the Drug-combination Nanoparticles

Published:2021-10 Issue: Volume: Page:
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Perazzolo Simone^ORCID,Shen Danny D.^ORCID,Ho Rodney J.Y.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference46 articles.

1. Highlights of virtual CROI 2021;Hayward;Lancet HIV,2021

2. CROI 2021;Kazi;Lancet Infect Dis,2021

3. Factors associated with interest in a long-acting HIV regimen: perspectives of people living with HIV and healthcare providers in four European countries;Akinwunmi;Sex Transm Infect,2021

4. A qualitative exploration of women's interest in long-acting injectable antiretroviral therapy across six cities in the women's interagency HIV study: intersections with current and past injectable medication and substance use;Philbin;AIDS Patient Care STDs,2021

5. Long-acting implants to treat and prevent HIV infection;Weld;Curr Opin HIV AIDS,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SAAM II: A general mathematical modeling rapid prototyping environment;CPT: Pharmacometrics & Systems Pharmacology;2024-06-11

2. Physiologically based Pharmacokinetic Model Validated to Enable Predictions Of Multiple Drugs in a Long-acting Drug-combination Nano-Particles (DcNP): Confirmation with 3 HIV Drugs, Lopinavir, Ritonavir, and Tenofovir in DcNP Products;Journal of Pharmaceutical Sciences;2024-06

3. Evaluation of Pharmacokinetics of a BCS Class III Drug with Two Different Study Designs: Tenofovir Alafenamide Monofumarate Film-coated Tablet;AAPS PharmSciTech;2024-05-30

4. Physiologically based pharmacokinetic model for predicting the biodistribution of albumin nanoparticles after induction and recovery from acute lung injury;Heliyon;2024-05

5. Role of Modeling and Simulation in Preclinical and Clinical Long-Acting Injectable Drug Development;The AAPS Journal;2023-10-17